Atlas Trials

Temodar and Sutent as Therapy for Melanoma

Clinical trial NCT00304200 · TERMINATED

Trial details

NCT number
NCT00304200
Sponsor
Northern California Melanoma Center
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Malignant Melanoma
Start date
2006-03-01
Primary completion
2007-10-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.